Pyxis Oncology, Inc. (PYXS)
4.31
-0.10
(-2.27%)
USD |
NASDAQ |
Dec 12, 16:00
4.31
0.00 (0.00%)
After-Hours: 19:09
Pyxis Oncology Research and Development Expense (TTM): 64.55M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Plus Therapeutics, Inc. | 7.624M |
| Pfizer Inc. | 10.13B |
| Ironwood Pharmaceuticals, Inc. | 95.29M |
| Akebia Therapeutics, Inc. | 42.02M |
| PTC Therapeutics, Inc. | 446.89M |